Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Aldosterone-receptor antagonism in hypertension
Pieter M. Jansen, AH Jan Danser, Ben P.M. Imholz, et al.
Journal of Hypertension (2009) Vol. 27, Iss. 4, pp. 680-691
Closed Access | Times Cited: 91

Showing 1-25 of 91 citing articles:

Hypertension
Luuk te Riet, Joep H.M. van Esch, Anton J.M. Roks, et al.
Circulation Research (2015) Vol. 116, Iss. 6, pp. 960-975
Open Access | Times Cited: 607
The renin‐angiotensin‐aldosterone system and its suppression
Marisa K. Ames, Clarke E. Atkins, Bertram Pitt
Journal of Veterinary Internal Medicine (2019) Vol. 33, Iss. 2, pp. 363-382
Open Access | Times Cited: 371
Addition of Spironolactone in Patients With Resistant Arterial Hypertension (ASPIRANT)
J. Václavík, Richard Sedlák, Martin Plachý, et al.
Hypertension (2011) Vol. 57, Iss. 6, pp. 1069-1075
Open Access | Times Cited: 301
Aldosterone: Role in the Cardiometabolic Syndrome and Resistant Hypertension
Adam Whaley‐Connell, Megan S. Johnson, James R. Sowers
Progress in Cardiovascular Diseases (2010) Vol. 52, Iss. 5, pp. 401-409
Open Access | Times Cited: 152
Aldosterone and arterial hypertension
Andreas Tomaschitz, Stefan Pilz, Eberhard Ritz, et al.
Nature Reviews Endocrinology (2009) Vol. 6, Iss. 2, pp. 83-93
Closed Access | Times Cited: 143
Sequential nephron blockade versus sequential renin–angiotensin system blockade in resistant hypertension
Guillaume Bobrie, Michael Frank, Michel Azizi, et al.
Journal of Hypertension (2012) Vol. 30, Iss. 8, pp. 1656-1664
Closed Access | Times Cited: 123
Mineralocorticoid Receptor-Associated Hypertension and Its Organ Damage: Clinical Relevance for Resistant Hypertension
Hirotaka Shibata, Hajime Itoh
American Journal of Hypertension (2012) Vol. 25, Iss. 5, pp. 514-523
Open Access | Times Cited: 115
Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension
GianLuca Colussi, Cristiana Catena, Leonardo A. Sechi
Journal of Hypertension (2012) Vol. 31, Iss. 1, pp. 3-15
Closed Access | Times Cited: 103
Aldosterone synthase inhibition in humans
Michel Azizi, Laurence Amar, Joël Ménard
Nephrology Dialysis Transplantation (2012) Vol. 28, Iss. 1, pp. 36-43
Open Access | Times Cited: 83
Hypertensive left ventricular hypertrophy risk: beyond adaptive cardiomyocytic hypertrophy
Edward D. Fröhlich, Arantxa González, Javier Dı́ez
Journal of Hypertension (2010) Vol. 29, Iss. 1, pp. 17-26
Closed Access | Times Cited: 80
Effect of Spironolactone in Resistant Arterial Hypertension
J. Václavík, Richard Sedlák, Jiří Jarkovský, et al.
Medicine (2014) Vol. 93, Iss. 27, pp. e162-e162
Open Access | Times Cited: 61
Addition of spironolactone in patients with resistant hypertension: A meta-analysis of randomized controlled trials
Liping Liu, Bing Xu, Yunfeng Ju
Clinical and Experimental Hypertension (2017) Vol. 39, Iss. 3, pp. 257-263
Closed Access | Times Cited: 49
Sympathetic Mechanisms, Organ Damage, and Antihypertensive Treatment
Guıdo Grassı, Gino Seravalle, Raffaella Dell’Oro, et al.
Current Hypertension Reports (2011) Vol. 13, Iss. 4, pp. 303-308
Closed Access | Times Cited: 56
Aldosterone and Mineralocorticoid Receptor Antagonists Modulate Elastin and Collagen Deposition in Human Skin
Thomas F. Mitts, Severa Bunda, Yanting Wang, et al.
Journal of Investigative Dermatology (2010) Vol. 130, Iss. 10, pp. 2396-2406
Open Access | Times Cited: 56
Mineralocorticoid receptor degradation is promoted by Hsp90 inhibition and the ubiquitin-protein ligase CHIP
Nourdine Faresse, Dorothée Ruffieux-Daidié, Mélanie Salamin, et al.
AJP Renal Physiology (2010) Vol. 299, Iss. 6, pp. F1462-F1472
Closed Access | Times Cited: 54
Eplerenone for hypertension
Tina SC Tam, May Wu, Sarah Masson, et al.
Cochrane library (2017) Vol. 2017, Iss. 2
Open Access | Times Cited: 43
Efficacy and safety of eplerenone in the management of mild to moderate arterial hypertension: Systematic review and meta-analysis
Francesco Pelliccia, Giuseppe Patti, Giuseppe Rosano, et al.
International Journal of Cardiology (2014) Vol. 177, Iss. 1, pp. 219-228
Closed Access | Times Cited: 43
Drug Therapy for Resistant Hypertension: Simplifying the Approach
Samuel J. Mann
Journal of Clinical Hypertension (2010) Vol. 13, Iss. 2, pp. 120-130
Open Access | Times Cited: 46
Blood pressure and neurohormonal responses to renal nerve ablation in treatment-resistant hypertension
Mustafa Ezzahti, Adriaan Moelker, Edith C. H. Friesema, et al.
Journal of Hypertension (2013) Vol. 32, Iss. 1, pp. 135-141
Closed Access | Times Cited: 40
Pharmacological treatment of aldosterone excess
Jaap Deinum, Niels P. Riksen, Jacques W.M. Lenders
Pharmacology & Therapeutics (2015) Vol. 154, pp. 120-133
Closed Access | Times Cited: 40
Eplerenone Versus Spironolactone in Resistant Hypertension: an Efficacy and/or Cost or Just a Men’s Issue?
Antonis A. Manolis, Theodora A. Manolis, Helen Melita, et al.
Current Hypertension Reports (2019) Vol. 21, Iss. 3
Closed Access | Times Cited: 34
Identification of new antiviral agents against Kaposi’s sarcoma-associated herpesvirus (KSHV) by high-throughput drug screening reveals the role of histamine-related signaling in promoting viral lytic reactivation
Jungang Chen, Lu Dai, Alana Goldstein, et al.
PLoS Pathogens (2019) Vol. 15, Iss. 12, pp. e1008156-e1008156
Open Access | Times Cited: 32
A perspective on small molecules targeting the Renin-Angiotensin-Aldosterone System and their utility in cardiovascular diseases: Exploring the structural insights for rational drug discovery and development
Nisha Bansal, Deepika Kathuria, Arockia Babu, et al.
RSC Medicinal Chemistry (2025)
Closed Access
Management of Hypertension in the Young: Role of Antihypertensive Medications
Joseph T. Flynn
Journal of Cardiovascular Pharmacology (2011) Vol. 58, Iss. 2, pp. 111-120
Closed Access | Times Cited: 40
Sequential comparison of aldosterone synthase inhibition and mineralocorticoid blockade in patients with primary aldosteronism
Laurence Amar, Michel Azizi, Joël Ménard, et al.
Journal of Hypertension (2013) Vol. 31, Iss. 3, pp. 624-629
Closed Access | Times Cited: 34
Page 1 - Next Page

Scroll to top